LeoFinWise was built for one reason: to give Indian retail traders the same morning briefing that professional desks prepare for themselves — before the market opens at 9:15 AM.
The foundation is CPR — Central Pivot Range — a technique developed by Frank Ochoa in his book Secrets of a Pivot Boss. Furthermore, we extend it with Wyckoff market structure, VSA volume analysis, Mansfield Relative Strength, and 17 data-backed research studies built from 5 years of NSE price history.
What we track
Every evening, after NSE closes, we calculate CPR levels — daily, weekly and monthly — for 200+ NSE stocks and indices including NIFTY 50 and BANKNIFTY. In addition, we screen for Narrow CPR (trending day signal), Virgin CPR (magnetic price levels), and CPR Migration (trend direction confirmation).
The result is a structured morning brief that tells you — before placing a single trade — which stocks have a directional bias, where the key decision zones are, and what institutional money (FII/DII) is doing across cash and F&O markets.
Our methodology
We are research-first. Every feature on the platform is backed by actual data from NSE price history, not opinion or prediction. For example, our Virgin CPR study analyses fill probability across thousands of historical instances. Similarly, our CPR Width study correlates intraday move size against CPR width to give you statistically grounded expectations — not guesswork.
As a result, you spend less time looking for trades and more time preparing for them with evidence.
Who this is for
LeoFinWise is designed for serious Indian retail traders who already understand technical analysis and want a data-driven edge. However, if you are new to CPR, our daily blog posts and YouTube channel break down the concepts from first principles — so you can build your understanding before subscribing to the platform.
Disclaimer
LeoFinWise is an educational and research tool. All content — CPR levels, structure analysis, research studies — is for educational purposes only. We are not SEBI-registered investment advisors. Nothing on this platform should be treated as investment advice. Please conduct your own research and consult a qualified financial advisor before trading.